Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
View Patent ↗The instant invention describes a method for crystallizing (−)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one from a solvent and anti-solvent solvent system and producing the crystalline product. The desired final crystal form, Form I, can be produced when using methanol or ethanol. Form II is isolated from 2-propanol and can be converted to the desired crystal form at low drying temperatures, such as between about a temperature of 40° C. and 50° C.
1. Form I of (−)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one, which is characterized by crystallographic D-spacings of 14.5, 8.5 and 7.2 Angstroms.
2. Form I according to claim 1 , characterized by crystallographic D-spacings of 14.5, 8.5, 7.2, 6.2, 4.4 and 4.2 Angstroms.
3. Form I according to claim 2 , characterized by crystallographic D-spacings of 14.5, 8.5, 8.0, 7.2, 6.7, 6.2, 4.4 and 4.2 Angstroms.
4. Form I according to claim 1 , having no detectable peaks for Form II or Form III in its X-ray powder diffraction pattern.
5. Form II of (−)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one, characterized by crystallographic D-spacings of 24.3, 6.9 and 5.5 Angstroms.
6. Form II according to claim 5 , characterized by crystallographic D-spacings of 24.3, 13.9, 6.9, 6.6, 5.5 and 4.3 Angstroms.
7. Form II according to claim 6 , characterized by crystallographic D-spacings of 24.3, 13.9, 8.0, 6.9, 6.6, 5.5, 4.5, 4.3, and 3.6 Angstroms.
8. Form II according to claim 5 , having no detectable peaks for Form I or Form III in its X-ray powder diffraction pattern.
9. Form III of (−)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one, characterized by crystallographic D-spacings of 12.2, 6.1 and 4.3 Angstroms.
10. Form III according to claim 9 , characterized by crystallographic D-spacings of 12.2, 8.1, 6.1, 4.7, 4.3 and 4.1 Angstroms.
11. Form III according to claim 10 , characterized by crystallographic D-spacings of 12.2, 8.1, 6.4, 6.1, 4.7, 4.3, 4.1, 3.7 and 3.6 Angstroms.
12. Form III according to claim 9 , having no detectable peaks for Form I or Form II in its X-ray powder diffraction pattern.
13. Form III according to claim 9 , which is further characterized by a DSC curve with a peak temperature of about 118° C. and an enthalpy of 34 J/g.
14. Form III according to claim 13 , which is further characterized by a thermogravimetric analysis indicating no significant weight loss from 43° C. to 137° C.